Detalhe da pesquisa
1.
Association between bariatric surgery and outcomes in chronic myeloid leukemia.
Cancer
; 129(12): 1866-1872, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882573
2.
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
Am J Hematol
; 98(11): 1711-1720, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635400
3.
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Clin Infect Dis
; 72(10): 1755-1763, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236406
4.
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy.
Cancer
; 127(19): 3541-3551, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182597
5.
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.
Cancer
; 127(14): 2489-2499, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793970
6.
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
Acta Haematol
; 143(6): 567-573, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32289808
7.
Navigating manuscript assessment: The new practitioner's guide to primary literature peer review.
J Oncol Pharm Pract
; 25(1): 94-100, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498322
8.
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.
Am J Hematol
; 98(1): E11-E14, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633516
9.
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies.
Am J Hematol
; 93(3): 401-407, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218851
10.
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 24(4): e168-e173, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212207
11.
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungals.
Leuk Lymphoma
; 64(1): 79-86, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222579
12.
Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia.
Open Forum Infect Dis
; 5(7): ofy167, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30090838
13.
Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia.
Expert Rev Hematol
; 9(4): 329-34, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26783163
14.
Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
Pharmacotherapy
; 35(11): 1037-51, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26598096
15.
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
Pharmacotherapy
; 34(11): 1198-208, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25266820
16.
L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-induced Hyperbilirubinemia.
Clin Lymphoma Myeloma Leuk
; 18(5): e191-e195, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550108
17.
Publication of pediatric and neonatal articles in the pharmacy literature from 2000 to 2010.
Am J Health Syst Pharm
; 70(7): 571-2, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515507